Your browser doesn't support javascript.
loading
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial.
Dijkstra, E A; Zwart, W H; Nilsson, P J; Putter, H; Roodvoets, A G H; Meershoek-Klein Kranenbarg, E; Frödin, J E; Nygren, P; Østergaard, L; Kersten, C; Verbiené, I; Cervantes, A; Hendriks, M P; Capdevila, J; Edhemovic, I; van de Velde, C J H; Marijnen, C A M; van Etten, B; Hospers, G A P; Glimelius, B.
Afiliação
  • Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: e.a.dijkstra@umcg.nl.
  • Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Putter H; Departments of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands.
  • Roodvoets AGH; Departments of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Meershoek-Klein Kranenbarg E; Departments of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Frödin JE; Department of Oncology-Pathology, Karolinska University Hospital, Uppsala.
  • Nygren P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Østergaard L; Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Kersten C; Department of Research, Sørlandet Hospital Trust, Kristiansand, Norway.
  • Verbiené I; Department of Oncology, Uppsala University, Uppsala, Sweden.
  • Cervantes A; Department of Medical Oncology, Biomedical Research Institute Incliva, University of Valencia, Valencia, Spain.
  • Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.
  • Capdevila J; Department of Medical Oncology, Vall Hebron Institute of Oncology (VHIO), Vall Hebron University Hospital. Autonomous University of Barcelona (UAB), Barcelona, Spain.
  • Edhemovic I; Department of Surgical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • van de Velde CJH; Departments of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam; Department of Radiation Oncology, Leiden University Medical Center, Leiden.
  • van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
ESMO Open ; 8(2): 101158, 2023 04.
Article em En | MEDLINE | ID: mdl-36871393
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans / Infant Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retais Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans / Infant Idioma: En Ano de publicação: 2023 Tipo de documento: Article